
Zybiraa 500 Tablet
Manufacturer
Zydus Cadila
Salt Composition
Abiraterone Acetate (500mg)
Key Information
Short Description
Zybiraa 500 Tablet is used in the treatment of cancer of the prostate gland.
Dosage Form
Tablet
Introduction
Zybiraa 500 Tablet is an anticancer medication used to treat prostate cancer that has spread to other parts of the body. It may be used with certain other medicines as part of combination chemotherapy. It is usually taken with another medicine called prednisolone to reduce unwanted side effects.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zybiraa 500 Tablet is to be taken empty stomach.
How it works
Zybiraa 500 Tablet is an anticancer medication that works by preventing androgen (male hormone) production in man. This is done by inhibiting an enzyme (CYP17) that is responsible for the production of androgen. This is how it slows down the growth of prostate cancer.
Quick Tips
Treats prostate cancer that has spread to other parts of the body Usually taken with another medicine called prednisolone to reduce unwanted side effects Must be taken on an empty stomach Always use effective birth control measures to prevent pregnancy while taking this medicine Your doctor may regularly monitor your liver function, blood pressure, and the level of potassium in your blood while you are having treatment with this medicine
Related Medicines

Biramet 500mg Tablet

Abione 500 Tablet

Abura 500 Tablet

Ahabir Tablet

Xbira 500 Tablet

Alkeprost 500mg Tablet

Zabpro 500mg Tablet

Mytera 500 Tablet

Abiracure 500mg Tablet

Abiratas 500mg Tablet
Frequently asked questions
Can Zybiraa 500 Tablet cure prostate cancer?
Zybiraa 500 Tablet is a hormonal treatment, and it does not cure cancer. It helps to prolong and improve the life of patients with advanced prostate cancer that has spread to other parts of the body. The use of Zybiraa 500 Tablet can decrease the frequency of fractures. There is also less frequent increase in pain.
Is Zybiraa 500 Tablet a chemotherapy drug?
Zybiraa 500 Tablet is not a chemotherapy drug. It is a hormonal treatment used to treat advanced prostate cancer in adult men, specifically those where the cancer has spread to other parts of the body. Zybiraa 500 Tablet works by stopping your body from making testosterone, which can slow down the growth of the cancer.
Why do I need to take prednisolone with Zybiraa 500 Tablet?
Your doctor prescribes prednisolone along with Zybiraa 500 Tablet. This combination lowers the risk of developing high blood pressure, fluid retention (excess water in your body), or a reduction in potassium levels. These potential side effects may occur due to Zybiraa 500 Tablet.
Does Zybiraa 500 Tablet affect liver?
Zybiraa 500 Tablet can cause serious liver problems. Rarely, Zybiraa 500 Tablet may even cause acute liver failure (liver dysfunction), which could be life-threatening. If you experience yellowing of the skin or eyes, darkening of your urine, or severe nausea and vomiting, tell your doctor immediately because these symptoms could signal liver problems.
How frequently should the liver investigations be done?
Before starting treatment with Zybiraa 500 Tablet, you will need liver enzyme tests. After the initial three months of treatment, follow-up liver enzyme tests will occur every two weeks for the first three months and then monthly thereafter. If you experience any clinical symptoms or signs suggestive of liver toxicity (like jaundice, dark urine, or severe nausea/vomiting), have your liver enzymes tested immediately. If liver enzyme levels increase beyond certain levels, your doctor may temporarily stop Zybiraa 500 Tablet
How to take Zybiraa 500 Tablet?
Zybiraa 500 Tablet should be taken on an empty stomach with water, at least one hour before eating or at least two hours after eating. Taking the medication with food may result in varying and higher levels of Zybiraa 500 tablet in your blood, which could cause harm. Always remember not to crush or chew the tablet.